Objective To examine the association between obesity subtypes and risk of early and late pre-eclampsia.Design Population-based retrospective study.Setting State of Missouri maternally linked birth cohort files.Population All singleton live births in the state of Missouri from 1989 to 2005.Methods The body mass index (BMI) was used to classify women as normal weight (BMI = 18.5-24.9 kg/m 2 ), class I obesity (BMI = 30-34.9 kg/m 2 ), class II obesity (BMI = 35-39.9 kg/m 2 ), class III obesity (BMI = 40-49.9 kg/m 2 ) or super-obesity (BMI ‡ 50 kg/m 2 ). Adjusted odds ratios (OR) and 95% confidence intervals (CI) for the association between obesity and the risk of pre-eclampsia were obtained from logistic regression models with adjustment for intracluster correlation.Results The rate of pre-eclampsia increased with increasing BMI, with super-obese women having the highest incidence (13.4%).Compared with normal weight women, obese women (BMI ‡ 30 kg/m 2 ) had a higher risk for pre-eclampsia (OR = 2.59, 95% CI = 2.87-3.01). This risk remained approximately the same for late-onset pre-eclampsia (preeclampsia occurring at 34 weeks or more of gestation) and was slightly reduced for early-onset pre-eclampsia (pre-eclampsia occurring at 34 weeks or less of gestation). Within each BMI category, the risk of pre-eclampsia increased with the rate of weight gain. Compared with normal weight mothers with moderate weight gain, super-obese women with a high rate of weight gain had the greatest risk for pre-eclampsia (OR = 7.52, 95% CI = 2.70-21.0).Conclusion BMI and rate of weight gain are synergistic risk factors that amplify the burden of pre-eclampsia among super-obese women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.